Evidence map›Paper›PMID 30889910›Full record

ArticleInternational journal of molecular sciences2019

HgS Inhibits Oxidative Stress Caused by Hypoxia through Regulation of 5-HT Metabolism Pathway.

Qiangqiang He, Ji Ma, Praveen Kumar Kalavagunta, Liangliang Zhou, Junyi Zhu, Jing Dong, Owais Ahmad, Yuzhi Du, Lixin Wei, Jing Shang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Pharmacology, Toxicology, and Rational Application of Cinnabar, Realgar, and Their Formulations.Evidence-based complementary and alternative medicine : eCAM · 2022
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Qiangqiang HeQinghai Key Laboratory of Tibetan Medicine Pharmacology and Safety Evaluation, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining, Qinghai 810008, China. 8075874@163.com.
Ji MaState Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China. matthewmj@163.com.
Praveen Kumar KalavaguntaState Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China. kgpk81@gmail.com.
Liangliang ZhouState Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China. zhoulliang@163.com.
Junyi ZhuState Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China. rainbow811@foxmail.com.
Jing DongState Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China. dongjingtx@gmail.com.
Owais AhmadSchool of Life Sciences, China Pharmaceutical University, Nanjing, 211198, China. owaisk90@outlook.com.
Yuzhi DuQinghai Key Laboratory of Tibetan Medicine Pharmacology and Safety Evaluation, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining, Qinghai 810008, China. yzdu@nwipb.cas.cn.
Lixin WeiQinghai Key Laboratory of Tibetan Medicine Pharmacology and Safety Evaluation, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining, Qinghai 810008, China. lxwei@nwipb.cas.cn.
Jing ShangQinghai Key Laboratory of Tibetan Medicine Pharmacology and Safety Evaluation, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining, Qinghai 810008, China. shangjing21cn@cpu.edu.cn.
China Pharmaceutical University · CNChinese Academy of Sciences · CN

Funding

A prospective joint research project of Jiangsu Province BY2016-078-02One Hundred Person Project of Chinese Academy of Sciences, Applied Basic Research Programs of Qinghai Province Y229461211Science and Technology Plan Projects in Qinghai Province 2015-ZJ-733
6 · The paper itself

Abstract

This study aims to reveal the potential relationship between 5-HT and oxidative stress in the organism. Our in vitro experiments in RIN-14B cells showed that anoxia leads the cells to the state of oxidative stress. Administration of exogenous 5-HT exacerbated this effect, whereas the inhibition of Tph1, LP533401 alleviated the oxidative stress. Several research articles reported that Cinnabar (consists of more than 96% mercury sulfide, HgS), which is widely used in both Chinese and Indian traditional medicine prescriptions, has been involved in the regulation of 5-HT. The present research revealed that HgS relieved the level of oxidative stress of RIN-14B cells. This pharmacological activity was also observed in the prescription drug Zuotai, in which HgS accounts for 54.5%, and these effects were found to be similar to LP533401, an experimental drug to treat pulmonary hypertension. Further, our in vivo experiments revealed that the administration of cinnabar or prescription drug Zuotai in zebrafish reduced the reactive oxygen species (ROS) induced by hypoxia and cured behavioral abnormalities. Taken together, in organisms with hypoxia induced oxidative stress 5-HT levels were found to be abnormally elevated, indicating that 5-HT could regulate oxidative stress, and the decrease in the 5-HT levels, behavioral abnormalities after treatment with cinnabar and Zuotai, we may conclude that the therapeutic and pharmacologic effect of cinnabar and Zuotai may be based on the regulation of 5-HT metabolism and relief of oxidative stress. Even though they aren't toxic at the present dosage in both cell lines and zebrafish, their dose dependent toxicities are yet to be evaluated.

Indexed as

AnimalsBehavior, AnimalCell HypoxiaCell LineLarvaMercury CompoundsMetabolic Networks and PathwaysModels, BiologicalOxidation-ReductionOxidative StressReactive Oxygen SpeciesRNA, MessengerSerotoninZebrafishcinnabarMercury CompoundsReactive Oxygen SpeciesRNA, MessengerSerotoninzuotai5-Hydroxytryptaminecinnabarhypoxiaoxidative stressreactive oxygen species

Identifiers

PMID30889910
PMCPMC6471647
OpenAlexW2921680238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.